Supplementen, getoetst aan het bewijs

Berberine

Sterkte van het bewijs: Deels onderbouwd

Bijgewerkt 2026-08-07

Deze gids is nog niet in uw taal vertaald en wordt daarom in het Engels getoond.

Kort antwoord

Does berberine lower blood sugar?

Pooled trial data show berberine reducing HbA1c by about 0.63 percentage points and fasting glucose by about 0.8 mmol/L in type 2 diabetes — a real effect, larger than any other supplement reviewed here. The literature is dominated by trials from a single region with known quality concerns, and berberine has genuine drug interactions. It is not a supplement to start without telling your prescriber.

Voordat u dit neemt

Overleg met uw voorschrijver voordat u dit bij een medicijn neemt, zeker bij bloedsuikerverlagende middelen. Stop nooit met een voorgeschreven medicijn om een supplement te nemen.

Interacties

  • Additive with glucose-lowering medication. Taken alongside metformin, insulin or a sulfonylurea, berberine can push glucose lower than either was meant to — a hypoglycaemia risk that rises with the drugs most likely to be in our readers' cabinets.1

    Vermijden

  • Inhibits intestinal P-glycoprotein, raising blood levels of drugs that depend on it. In animals, berberine increased digoxin exposure by up to 70% and ciclosporin exposure by up to 96%. Both have narrow margins between a working dose and a toxic one.2

    Vermijden

  • Modelling that accounts for both CYP3A and P-glycoprotein inhibition predicts high-dose berberine (300 mg three times daily) will raise exposure to some CYP3A substrates. These are simulations, not measured human interactions, and the authors call for controlled studies.3

    Voorzichtig

Wie het niet moet nemen

  • Not for use in pregnancy or while breastfeeding. Berberine crosses the placenta and is excreted in breast milk, and it displaces bilirubin from albumin — the mechanism behind kernicterus in newborns.

    Vermijden

  • Not for infants or young children, for the same reason.

    Vermijden

  • If you take any prescription medicine at all, talk to your prescriber before starting berberine rather than after. This is the supplement on this site with the most real interaction potential.

    Voorzichtig

Ons oordeel

The strongest evidence of anything on this page, from the weakest evidence base — and with real interaction risk attached. Worth discussing with a prescriber; not worth starting quietly.

Wat wij bij u mogen zeggen en verkopen

Gezondheidsclaims voor deze producten zijn in uw regio niet toegestaan, dus deze pagina bevat geen enkele commerciële link. Zij is uitsluitend informatief.

In uw regio worden geen commerciële links getoond.

Hoe u de bewijslabels leest

Elke bewering op deze pagina draagt een label dat aangeeft hoeveel gewicht zij kan dragen. Het beschrijft de sterkte van de bevinding, niet het aanzien van het tijdschrift.

  • Sterk bewijsEen grote gerandomiseerde studie, een lang cohortonderzoek, of overeenstemming tussen meerdere daarvan.
  • Voorlopig bewijsEcht, maar dun — klein, kort, observationeel of nog niet gerepliceerd.
  • OmstredenDeskundige onderzoekers zijn het openlijk oneens. Wij kiezen geen kant voor u.

What the trials found

A 2022 meta-analysis pooled 37 randomised trials covering 3,048 people with type 2 diabetes. The effect sizes are not trivial: reductions on the order of a modest pharmaceutical.

The same analysis reported no increase in total adverse events or in hypoglycaemia risk when berberine was used alone or alongside oral glucose-lowering drugs — though that is a different question from whether it is safe alongside every other medication someone might be taking.

Wat het bewijs zegt

  • Across 37 randomised trials in 3,048 people with type 2 diabetes, berberine reduced HbA1c by 0.63 percentage points, fasting glucose by 0.82 mmol/L and two-hour post-load glucose by 1.16 mmol/L.1

    Voorlopig bewijs

  • The size of the effect depended on how high the participant's baseline glucose and HbA1c were — the benefit concentrates in people whose numbers were worst to begin with.1

    Voorlopig bewijs

Why we tier this as emerging, not strong

The pooled figures look impressive, and the evidence base underneath them is not. That analysis searched four Chinese-language databases alongside the international ones, and the berberine trial literature is heavily concentrated in trials published there — a body of work with documented concerns about methodological quality and publication bias.

This is not a claim that the trials are wrong. It is a statement about how much a pooled average from that literature can be relied on, and the honest answer is: less than the confidence interval suggests. Larger, independently run trials would settle it.

Wat het bewijs zegt

  • The pooled berberine evidence draws substantially on trials indexed in Chinese-language databases, a literature with recognised quality and publication-bias concerns.1

    Voorlopig bewijs

The interaction problem

Berberine inhibits intestinal P-glycoprotein, the transporter that limits how much of certain drugs get absorbed. Block it and those drugs reach higher levels than prescribed. In animal work, digoxin and ciclosporin exposure both rose substantially — two drugs where the gap between therapeutic and toxic is narrow.

Our audience is the reason this matters more here than on a general wellness site. People reading about glucose supplements are disproportionately people already taking glucose-lowering drugs, and berberine's effect is additive with all of them.

Wat het bewijs zegt

  • Berberine increased digoxin exposure by up to 70% and ciclosporin exposure by up to 96% in animal studies, through inhibition of intestinal P-glycoprotein.2

    Voorlopig bewijs

  • The same animal work found no significant change in CYP3A activity, while pharmacokinetic modelling predicts clinically relevant CYP3A-mediated interactions at high berberine doses — the two lines of evidence do not fully agree.2,3

    Voorlopig bewijs

Veelgestelde vragen

Is berberine as good as metformin?
Some trials compare the two directly and report similar glucose reductions, but they are small and mostly from one literature. Metformin has decades of outcome data behind it and berberine does not. They are not interchangeable, and swapping one for the other is a decision for a prescriber.
Can I take berberine with metformin?
Their effects on glucose add up, which can push you lower than either dose intended. That is a conversation to have with whoever prescribed the metformin before you start, not after.
How long does the effect last?
Most trials in the pooled analysis ran for a few months. There is little long-term data, and no trial has shown that berberine reduces the complications that matter — only the numbers that predict them.

Literatuur

  1. 1.Xie W, Su F, Wang G, Peng Z, Xu Y, Zhang Y, et al. (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology. 10.3389/fphar.2022.1015045
  2. 2.Qiu W, Jiang XH, Liu CX, Ju Y, Jin JX (2009). Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp. Phytotherapy Research. 10.1002/ptr.2808
  3. 3.Adiwidjaja J, Boddy AV, McLachlan AJ (2022). Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib. European Journal of Clinical Pharmacology. 10.1007/s00228-021-03266-y

Lees hierna